Zymeworks (ZYME) Non-Current Deferred Revenue (2021 - 2026)
Zymeworks (ZYME) posted Non-Current Deffered Revenue of $14.61 million for Q1 2026, unchanged from $14.61 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Zymeworks (ZYME) Non-Current Deferred Revenue (2021 - 2026) Analysis & Trends
Since Q4 2021, Zymeworks has reported Non-Current Deffered Revenue for 16 quarters.
- Annual Non-Current Deffered Revenue shows a four-year compound annual growth rate of -18.4% (FY2021 to FY2025).
- In prior years, Zymeworks' Non-Current Deffered Revenue was $14.61 million in FY2024 (-55.7%), $32.94 million in FY2023 (+7.7%), $30.59 million in FY2022 (-7.1%) and $32.94 million in FY2021.
- Quarterly Non-Current Deffered Revenue has run from a low of $14.61 million in Q4 2025 to a high of $32.94 million in Q2 2024 over five years.
- On a year-over-year basis, Non-Current Deffered Revenue increased in 1 of the last eight quarters, with an average decline of 26.9%.
- The strongest year-over-year quarter for Non-Current Deffered Revenue in the past five years was Q2 2024, with growth of 7.7%; the weakest was Q3 2024, with a decline of 55.7%.
- According to Business Quant data, Non-Current Deffered Revenue for the three prior quarters was $14.61 million (Q4 2025), $14.61 million (Q3 2025) and $14.61 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Zymeworks | 2.24 Bn | 1.27 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 14.61 Mn |
| Dec 31, 2025 | 14.61 Mn |
| Sep 30, 2025 | 14.61 Mn |
| Jun 30, 2025 | 14.61 Mn |
| Mar 31, 2025 | 14.61 Mn |
| Dec 31, 2024 | 14.61 Mn |
| Sep 30, 2024 | 14.61 Mn |
| Jun 30, 2024 | 32.94 Mn |
| Mar 31, 2024 | 32.94 Mn |
| Dec 31, 2023 | 32.94 Mn |
| Sep 30, 2023 | 32.94 Mn |
| Jun 30, 2023 | 30.59 Mn |
| Mar 31, 2023 | 30.59 Mn |
| Dec 31, 2022 | 30.59 Mn |
| Sep 30, 2022 | 32.94 Mn |
| Dec 31, 2021 | 32.94 Mn |
API Access
Zymeworks Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ZYME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();